TerminatedNCT00605995
Add-on Simvastatin in Schizophrenia Trial
Medication studyAges 18–70Israel
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- Ramat GanSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2008
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 15
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Israel
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00605995
- Official title
Show the full official title
Add-on Simvastatin in Schizophrenia Trial
Recruitment & locations
TerminatedRamat Gan
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Simvastatin.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
